Policy

The state of Hawaii has mandated employer-based coverage since 1974, offering an opportunity for learning as implementation of the Affordable Care Act ramps up.

Could transparency in healthcare pricing decrease the disparity of costs in routine procedures?

Ongoing shortages of common oncology chemotherapies have compelled physicians to substitute more expensive drugs, delay or suspend clinical trials, or even skip doses of chemotherapy, according to survey results gathered by a team from the University of Pennsylvania.

Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that in regard to payers impacting the use of immunotherapies, most payers have decided they will respect the judgment of the Food and Drug Administration, Centers for Medicare & Medicaid Services and the National Comprehensive Cancer Network.

As the future of healthcare reform is considered, many discussions seem to center around the concept of shared decision-making, specifically in regards to the patient's role in managing their own healthcare choices. However, in light of new research, the notion of patient participation is being questioned.

The panel at the American Thoracic Society 2013 International Conference continued discussions that suggested high rates of hospital readmissions may be an indicator of poor initial treatment, or failure to coordinate care. Further, these rates, which varied dramatically from hospital to hospital, were often excessively expensive.